Johnson & Johnson Coronavirus vaccine illustration

Dado Ruvic | Reuters

Johnson & Johnson hasn’t manufactured a lot of doses of its single-shot Covid-19 vaccine ahead of its regulatory clearance expected later this month.

The administration has learned in the last couple of weeks that J&J will only have “a few million” doses ready when the vaccine is likely authorized by the Food and Drug Administration, Jeff Zients, Biden’s Covid czar, told reporters Wednesday during a White House news briefing on the pandemic. 

This is a developing story. Please check back for updates.


READ  WHO says the record number of coronavirus cases isn't just because of more testing


Please enter your comment!
Please enter your name here